Abstract
The consumption of plant-based food is important for health promotion, especially concerning the prevention and management of chronic diseases. Flavonoids are the main bioactive compounds in citrus fruits, with multiple beneficial effects, especially antidiabetic effects. We systematically review the potential antidiabetic action and molecular mechanisms of citrus flavonoids based on in vitro and in vivo studies. A search of the PubMed, EMBASE, Scopus, and Web of Science Core Collection databases for articles published since 2010 was carried out using the keywords citrus, flavonoid, and diabetes. All articles identified were analyzed, and data were extracted using a standardized form. The search identified 38 articles, which reported that 19 citrus flavonoids, including 8-prenylnaringenin, cosmosiin, didymin, diosmin, hesperetin, hesperidin, isosiennsetin, naringenin, naringin, neohesperidin, nobiletin, poncirin, quercetin, rhoifolin, rutin, sineesytin, sudachitin, tangeretin, and xanthohumol, have antidiabetic potential. These flavonoids regulated biomarkers of glycemic control, lipid profiles, renal function, hepatic enzymes, and antioxidant enzymes, and modulated signaling pathways related to glucose uptake and insulin sensitivity that are involved in the pathogenesis of diabetes and its related complications. Citrus flavonoids, therefore, are promising antidiabetic candidates, while their antidiabetic effects remain to be verified in forthcoming human studies.
Highlights
The genus Citrus covers a large diversity of trees and shrubs, containing 16 species or 156 species, and is native to subtropical and tropical regions of Asia and Oceania (Queensland and Australia) [1].The high phenotypic and genetic variability of the Citrus genus is explained by the sexual compatibility between the Citrus species, allowing natural hybridization, and the long history of human intervention by interspecific hybridization to obtain more useful varieties of the plants [2]
The results showed that the phosphoinositide 3-kinases (PI3K), protein kinase B (Akt), and the protein kinase A (PKA) pathways were involved in the increase in glucose uptake
Nobiletin reduced phosphor-kappaB-α (IκB-α) expression, with the subsequent inhibition of phosphor-p65 activity. These results indicate that the treatment with nobiletin mitigated cardiac dysfunction and interstitial fibrosis, which may be due to its constructive action on the suppression of the c-Jun N-terminal kinase (JNK), P38, and nuclear factor kappa B (NF-κB) signaling pathways
Summary
Gopalsamy Rajiv Gandhi 1,2,3 , Alan Bruno Silva Vasconcelos 4 , Ding-Tao Wu 5 , Hua-Bin Li 6 , Poovathumkal James Antony 7 , Hang Li 1,2 , Fang Geng 8 , Ricardo Queiroz Gurgel 3 , Narendra Narain 9 and Ren-You Gan 1,2,8, *. Chengdu National Agricultural Science and Technology Center, Chengdu 600103, China. Received: 25 August 2020; Accepted: 19 September 2020; Published: 23 September 2020
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
